Resultado de búsqueda
Neil Weir. Chief Executive Officer. Neil was previously Senior Vice-President, Discovery, at UCB S.A., overseeing an integrated portfolio of small molecule and antibody therapeutic projects in the areas of immunology and neurology.
← Back to Team. Neil Weir. Venture Partner. Neil joined SV as a Venture Partner in 2020. He is Chief Executive Officer of Sitryx Therapeutics, an SV-created company working in the field of immunometabolism to bring novel medicines to unmet needs in inflammation, autoimmunity and immuno-oncology.
9 de may. de 2023 · 9th May 2023. Our CEO, Neil Weir, spoke as part of the Biotech Leaders Showcase at LSX World Congress in May about resetting the immune system in chronic inflammatory disease. You can view the presentation here: https://youtu.be/15rY7_MdZz4.
Otolaryngology: An Illustrated History. Neil Weir. Butterworths, 1990 - Medical - 290 pages. Published to coincide with the XIVth World Congress of Otolaryngology held in Madrid in September...
Neil Weir - Sitryx | LinkedIn. United Kingdom. 926 followers 500+ connections. View mutual connections with Neil. Welcome back. Activity. 🎉We are happy to announce that we have successfully...
15 de abr. de 2021 · Sitryx Therapeutics Neil Weir biopharmaceutical Iain Kilty immuno-oncology immunometabolism. http://www.sitryx.com. Sitryx further strengthens leadership team with the appointment of Iain...
24 de mar. de 2021 · Neil Weir, Chief Executive Officer of Sitryx, said: “Pierre’s vast global experience in guiding companies through various stages of growth is unrivalled and his expertise in developing and...
